Dow Jones

40 801,61

1,47%

DAX

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NYSE
Teva Pharmaceutical Industries Ltd (TEVA)
Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NYSE:TEVA

<< Précédent 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
01/12/2014	17h50	Business Wire	Teva Announces Launch of Generic Exforge HCT® Tablets in the United States	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
26/11/2014	17h26	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
26/11/2014	17h13	Business Wire	Prof. Yitzhak Peterburg Elected Chairman of Teva’s Board of Directors	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
18/11/2014	14h00	Business Wire	Teva Launches Liquid Formulation of TREANDA® (bendamustine HCI) Injection in U.S.	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
07/11/2014	14h00	Business Wire	Teva Presents Data for Investigational Short-Acting Beta-Agonist Inhaler (Albuterol MDPI) at 2014 Annual Scientific Meeting o...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
07/11/2014	14h00	Business Wire	Teva Presents Positive Safety & Efficacy Data for QNASL® (Beclomethasone Dipropionate) Nasal Aerosol in Treating Children wi...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
04/11/2014	14h00	Business Wire	Teva & Active Biotech Announce Expansion of Laquinimod Clinical Development Program with New Trial in Primary Progressive Mul...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
30/10/2014	12h03	Business Wire	Teva Reports Third Quarter 2014 Results	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
08/10/2014	14h00	Business Wire	Teva Announces Initiation of New Drug Application & Positive Results from Second Human Abuse Liability Study for CEP-33237 (H...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
07/10/2014	00h18	Dow Jones News	U.S. Hot Stocks: Hot Stocks to Watch	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
06/10/2014	19h59	Business Wire	Teva to Report Third Quarter 2014 Financial Results on October 30, 2014	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
06/10/2014	14h30	Business Wire	Teva Announces Results of Strategic Review of Core Specialty Therapeutic Areas	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
12/09/2014	15h00	Business Wire	Teva Presents Gene Expression Analysis at Joint Actrims-Ectrims Meeting Demonstrating Copaxone® (Glatiramer Acetate Injectio...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
12/09/2014	14h00	Business Wire	Teva Presents New Clinical Safety Data in RRMS Patients Treated with Laquinimod for Two or More Years at Joint ACTRIMS-ECTRIM...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
11/09/2014	15h29	Business Wire	Teva Presents New Data Which Demonstrate Reduction of Injection-Related Adverse Events with the Less Frequent Dosing of Three...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
11/09/2014	15h00	PR Newswire (Canada)	Teva Canada annonce le lancement de (Pr)Teva-Escitalopram, une version générique de (Pr)Cipralex®	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
10/09/2014	20h22	PR Newswire (Canada)	Teva Canada Announces the Launch of (Pr)Teva-Escitalopram, a Generic of (Pr)Cipralex®	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
08/09/2014	14h00	Business Wire	Successful Completion of Phase III Program for Teva’s Reslizumab Two More Phase Iii Studies Support the Benefits of Reslizu...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
04/09/2014	14h00	Business Wire	Teva Announces Launch of Generic Baraclude® Tablets, 0.5mg and 1mg, in the United States	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
04/09/2014	14h00	Business Wire	Teva to Present at the Morgan Stanley Global Healthcare Conference	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
03/09/2014	14h00	Business Wire	Teva Launches SYNCareTM Home Administration Support Program for Patients on SYNRIBO® (Omacetaxine Mepesuccinate) for Injection	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
03/09/2014	14h00	Business Wire	Data to be Presented at MS Boston 2014: Joint ACTRIMS-ECTRIMS Meeting Underscore Teva’s Commitment to Developing Solutions ...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
03/09/2014	08h00	Business Wire	Teva Announces UK High Court Gives Positive Judgment in the Company’s Patent Case Against AstraZeneca	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
02/09/2014	14h01	Business Wire	Teva’s Reslizumab Delivers Clinically & Statistically Significant Reduction in Asthma Exacerbations in Two Pivotal Phase II...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
21/08/2014	22h20	Dow Jones News	U.S. Restricts Narcotic Pain Drug Prescriptions	NYSE:TEVA	Teva Pharmaceutical Industries Ltd.
21/08/2014	22h01	PR Newswire (US)	OncoGenex Announces Update on Phase 3 ENSPIRIT Trial Evaluating Custirsen in Advanced Non-Small Cell Lung Cancer	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
21/08/2014	21h30	Dow Jones News	DEA Restricts Narcotic Pain Drug Prescriptions	NYSE:TEVA	Teva Pharmaceutical Industries Ltd.
08/08/2014	00h05	Dow Jones News	ADR Shares End Lower; Statoil Shares Trade Actively	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
07/08/2014	18h04	Business Wire	Teva Comments on Receipt of First Paragraph IV Notice for COPAXONE® 40 mg/mL (glatiramer acetate injection) Formulation	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
07/08/2014	12h30	PR Newswire (Canada)	OncoGenex Pharmaceuticals Announces Appointment of John A. Bencich as Vice President and Chief Financial Officer	NYSE:TEVA	Teva Pharmaceutical Industries Ltd